Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands

Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry

(2015) J. Beyer-Westendorf et al.   EUROPACE

Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence

(2015) B. Vrijens et al.   EUROPACE

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

(2014) Paul L. Hess et al.   AMERICAN HEART JOURNAL

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

(2014) François Laliberté et al.   CURRENT MEDICAL RESEARCH AND OPINION

Laboratory Monitoring of the Non–Vitamin K Oral Anticoagulants∗

(2014) Andrew D. Blann et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Estimation of the impact of warfarin’s time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials

(2014) Alpesh Amin et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

When the Rubber Meets the Road: Adherence and Persistence with Non–Vitamin K Antagonist Oral Anticoagulants and Old Oral Anticoagulants in the Real World—A Problem or A Myth ?

(2014) Deepa Suryanarayan et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Ensuring medication adherence with direct oral anticoagulant drugs

(2014) Alessandro Di Minno et al.   THROMBOSIS RESEARCH

Disadvantages of VKA and requirements for novel anticoagulants

(2013) Raji Shameem et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

(2013) Ammar Majeed et al.   CIRCULATION

From monitoring to vigilance about patient adherence to new oral anticoagulants

(2013) B. Vrijens et al.   EUROPACE

Dabigatran, ROCKET Atrial Fibrillation, and Beyond: Basic Science, Mechanisms of Agents, Monitoring, and Reversal

(2013) K. A. Bauer   STROKE

New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes

(2012) Raffaele De Caterina et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Evolution of Oral Anticoagulant Therapy

(2012) Christopher Dittus et al.   PRIMARY CARE

Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing Histories

(2011) Terrence F. Blaschke et al.   Annual Review of Pharmacology and Toxicology

Drug and dietary interactions of warfarin and novel oral anticoagulants: an update

(2011) Edith Nutescu et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Prevalence and determinants of pharmacy shopping behaviour

(2010) H. Buurma et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

The new oral anticoagulants

(2009) D. Garcia et al.   BLOOD

Genotypes Associated With Reduced Activity of VKORC1 and CYP2C9 and Their Modification of Acenocoumarol Anticoagulation During the Initial Treatment Period

(2009) M Teichert et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A genome-wide association study of acenocoumarol maintenance dosage

(2009) Martina Teichert et al.   HUMAN MOLECULAR GENETICS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Medication Compliance and Persistence: Terminology and Definitions

(2007) Joyce A. Cramer et al.   VALUE IN HEALTH